发明名称 |
TREATING ONCOGENIC RAS DRIVEN CANCERS |
摘要 |
Oncogenic Ras-driven cancer is treated with agent by interrupting pathway comprising activation of Akt by oncogenic Ras, activated Akt causing phosphorylation of eNOS at S1177 site of eNOS to provide activated eNOS in cancer cells and activated eNOS causing activation of wildtype Ras by nitrosylation thereof at C118 to provide GTP-bound activated wildtype H and N Ras. L-NAME can be orally administered to interrupt this pathway. Wortmannin can be administered intravenously to interrupt this pathway. Novel siRNAs are disclosed useful to interrupt said pathway.
|
申请公布号 |
US2011003887(A1) |
申请公布日期 |
2011.01.06 |
申请号 |
US20090863600 |
申请日期 |
2009.01.09 |
申请人 |
DUKE UNIVERSITY |
发明人 |
COUNTER CHRISTOPHER M.;LIM KIAN-HUAT;ANCRILE BROOKE;KASHATUS DAVID F |
分类号 |
A61K31/366;A61K31/221;A61P35/00;C07H21/02 |
主分类号 |
A61K31/366 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|